Portfolio company
Reservoir Neuroscience
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops therapeutics to repair the blood-brain barrier for patients with age-related neurodegeneration and chronic epilepsy.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
EnClear Therapies
The company develops a drug delivery system for the cerebrospinal fluid to treat patients with neurological diseases and brain tumours.
BE Therapeutics
This company develops engineered brain and spinal cord tissues to repair central nervous system damage for patients with neurodegeneration, stroke or trauma.
Neurona Therapeutics
This company develops off-the-shelf regenerative neural cell therapies for patients with drug-resistant epilepsy and other chronic disorders of the central nervous system.
Neuraworx
This company develops a wearable neurostimulation device that enhances the brain's waste clearance system to treat neurodegenerative diseases and traumatic brain injuries.
Neumirna Therapeutics
This biotechnology company develops microRNA-based therapies to treat patients with neurological disorders, including drug-resistant epilepsy and Parkinson's disease.
Cordance Medical
This company develops a focused ultrasound device to open the blood-brain barrier for clinicians treating patients with brain tumours and other neurological diseases.
Brain-to-Computer Interface
This company develops ultrasound-based brain-computer interfaces to treat neurological and psychiatric conditions for patients with unmet medical needs.
Neurosciences
This company develops precision sodium channel therapeutics to treat patients with neurological conditions such as genetic epilepsy and chronic neuropathic pain.
